U.S. judge rejects Bayer's bid to block Johnson & Johnson prostate cancer drug claims
Published on April 17, 2026.
A federal judge has rejected a bid by Bayer to block Johnson & Johnson (J.N. for an injunction, stating it is unlikely the company will succeed. The judge stated that the company's claim that its drug, which is sold in the US for $2.99.
Related Articles
Japanese men continue to be arrested in string of child prostitution, rape cases in Laos - TokyoReporter
Despite a rare warning, Japanese men continue to be arrested in Laos for child prostitution and statutory rape, despite this being a taboo topic in both countries.
Lee signs TennCare gender transition ban: Week in Politics
Gov.com.com article:
Axios C-Suite: What Jim learned for the week of April 18
The week of April 18 saw notable political developments, particularly in AOC's potential for presidential candidacy and Meta's rise in prominence.